Deprescribing of psychotropic medication in a 30-year-old man with learning disability [0.03%]
学习障碍患者的抗精神病药物减停
Danielle Adams,Indermeet Sawhney
Danielle Adams
A 30-year-old man with learning disability, living in a residential home with no documented mental health diagnosis, on the autistic spectrum was prescribed carbamazepine, olanzapine and propranolol to manage behaviour on a long-term basis....
Deprescribing and managing polypharmacy in frail older people: a patient-centred approach in the real world [0.03%]
frail老年人的减药和多药治疗管理：现实世界中的以患者为中心的方法
Lelly Oboh,Mohammed Salman Qadir
Lelly Oboh
Polypharmacy is common in people with multiple long-term conditions (LTC) to relieve symptoms and improve quality of life. However, it is also associated with poor outcomes and increased risk of adverse drug events in older people. Older pe...
Ian Scott,Kristen Anderson,Christopher Freeman
Ian Scott
Avoiding inappropriate polypharmacy has become increasingly recognised as a safety imperative for older patient care. Deprescribing is an active process of reviewing all medications being used by individual patients that prompts clinicians ...
Deprescribing in older adults: a new concept for nurses in administering medicines and as prescribers of medicine [0.03%]
老年人减药：护士用药和处方的新理念
Corina Naughton,Nicky Hayes
Corina Naughton
Deprescribing is a new and emerging theme in the care of older adults living with multimorbidities including frailty. Deprescribing requires a comprehensive review of risk and benefits of a medication in the context of the quality of remain...
Shane Cullinan,Christina Raae Hansen,Stephen Byrne et al.
Shane Cullinan et al.
Older patients often have multimorbidity, frequently resulting in polypharmacy. Independently, multimorbidity and polypharmacy are among the biggest risk factors for inappropriate medication, adverse drug reactions, adverse drug events and ...
Polly Duncan,Martin Duerden,Rupert A Payne
Polly Duncan
Polypharmacy is an increasing and global issue affecting primary care. Although sometimes appropriate, polypharmacy can also be problematic, leading to a range of adverse consequences. Deprescribing is the process of supervised withdrawal o...
Sam Barnett-Cormack
Sam Barnett-Cormack
An exploration of the patient experience of managing medicines for multiple long-term conditions from the patient perspective. Difficulties and coping strategies are presented, with some exploration of the ways that clinicians, prescribers ...
Impact of medication review, within a shared decision-making framework, on deprescribing in people living in care homes [0.03%]
在共享决策框架下的用药评价对护理机构中居民减药的影响研究
Wasim Baqir,Julian Hughes,Tania Jones et al.
Wasim Baqir et al.
Objectives: The key objectives of this study were to quantify extent of prescribing, reasons for deprescribing, common therapeutic groups of medicines deprescribed and adverse events. ...
Impact of joint consultation by a clinical pharmacist and a clinical geriatrician to improve inappropriate prescribing for elderly patients [0.03%]
临床药师与老年医学家联合咨询对老年人不适当用药的改善作用
J J W Ros,T J Koekkoek,A Kalf et al.
J J W Ros et al.
Objective: Appropriate prescribing is a key quality element in medication safety. It is unclear if therapeutic interventions resulting from medication review lead to clinically relevant improvements. The effect of medicat...